Department of Urology, Markhot Ferenc University Teaching Hospital, Eger, Hungary.
Department of Medical Microbiology, Semmelweis University, Nagyvárad tér 4, 1089, Budapest, Hungary.
Sci Rep. 2020 Jul 6;10(1):11042. doi: 10.1038/s41598-020-67443-2.
The microbiota isolated from the urine of bladder carcinoma patients exhibits significantly increased compositional abundance of some bacterial genera compared to the urine of healthy patients. Our aim was to compare the microbiota composition of cancerous tissues and urine samples collected from the same set of patients in order to improve the accuracy of diagnostic measures. Tissue samples were collected from patients during cancer tissue removal by transurethral resection. In parallel, urine samples were obtained by transurethral resectoscopy from the same patients. The V3-V4 region of the bacterial 16S rRNA gene was sequenced and analyzed using the Kraken pipeline. In the case of four patients, duplicate microbiota analysis from distant parts of the cancerous tissues was highly reproducible, and independent of the site of tissue collection of any given patient. Akkermansia, Bacteroides, Clostridium sensu stricto, Enterobacter and Klebsiella, as "five suspect genera", were over-represented in tissue samples compared to the urine. To our knowledge, this is the first study comparing urinary and bladder mucosa-associated microbiota profiles in bladder cancer patients. More accurate characterization of changes in microbiota composition during bladder cancer progression could provide new opportunities in the development of appropriate screening or monitoring methods.
从膀胱癌患者尿液中分离出的微生物组与健康患者的尿液相比,某些细菌属的组成丰度显著增加。我们的目的是比较来自同一组患者的癌症组织和尿液样本的微生物组成,以提高诊断措施的准确性。组织样本是在经尿道切除肿瘤组织期间从患者身上采集的。同时,通过对同一患者进行经尿道切除膀胱镜检查获得尿液样本。使用 Kraken 管道对细菌 16S rRNA 基因的 V3-V4 区进行测序和分析。在四名患者的情况下,来自癌症组织不同部位的重复微生物组分析具有高度可重复性,并且与任何给定患者的组织采集部位无关。与尿液相比,Akkermansia、Bacteroides、Clostridium sensu stricto、Enterobacter 和 Klebsiella 等“五个可疑属”在组织样本中过度表达。据我们所知,这是首次在膀胱癌患者中比较尿液和膀胱黏膜相关微生物组谱的研究。更准确地描述膀胱癌进展过程中微生物组组成的变化可能为开发适当的筛查或监测方法提供新的机会。